已核实 DOI PubMed 相关产品: 253

Biomimetic Molybdenum Sulfide-Catalyzed Tumor Ferroptosis and Bioimaging

Journal 2023 · IF 13.3 · 19(16): 2207544 · 发表于 2023 年 1 月 22 日
作者: Yan Xu,Weitao Yang,Yi Han,Kexin Bian,Weiwei Zeng,Liangwen Hao,Hui Wang,Yingsheng Cheng,Peijun Wang,Bingbo Zhang
阅读全文 在 PubMed 查看

摘要

The chemical generation of singlet oxygen ( 1 O 2 ) by the MoO 4 2− -catalyzed disproportionation of hydrogen peroxide (H 2 O 2 ) has been widely applied in numerous catalytic processes; however, such molybdate ions cannot be administered for redox-based cancer therapeutics. This work reports the albumin-mediated biomimetic synthesis of highly active molybdenum sulfide (denoted MoB) nanocatalysts that mediate the simultaneous generation of 1 O 2 and superoxide anion (O 2 •− ) from H 2 O 2 , which is relatively abundant in malignant tumors. The MoB-catalyzed reactive oxygen species (ROS) are able to activate the ferroptosis pathway and cause lipid peroxidation for efficient cancer therapy. Furthermore, for the first time, the catalytic activity of MoB is visualized in situ. Moreover, a catalytic imaging modality based on MoB is developed for specific imaging of inflammation diseases without background interference. Therefore, this study presents a biomimetic strategy toward Mo-based nanocatalysts for ROS-facilitated tumor ferroptosis and catalytic imaging.

本研究中使用的阿拉丁产品

253 款产品在本文中被引用